Literature DB >> 8706628

The nature and function of putative gonadotropin surge-attenuating/inhibiting factor (GnSAF/IF).

P A Fowler1, A Templeton.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8706628     DOI: 10.1210/edrv-17-2-103

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


× No keyword cloud information.
  5 in total

1.  Human follicular fluid from superovulated women inhibits progesterone receptor-dependent gonadotropin-releasing hormone self-priming in an estrous cycle-dependent manner in the rat.

Authors:  A Gordon; R Aguilar; J C Garrido-Gracia; C Bellido; Y Millán; S Guil-Luna; J A García-Velasco; E Bellido-Muñoz; J Martín de las Mulas; J E Sánchez-Criado
Journal:  J Endocrinol Invest       Date:  2010-05-17       Impact factor: 4.256

2.  Changes in the mouse estrus cycle in response to BRCA1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer.

Authors:  Hao Hong; Hai-Yun Yen; Amy Brockmeyer; Ying Liu; Rajas Chodankar; Malcolm C Pike; Frank Z Stanczyk; Robert Maxson; Louis Dubeau
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

3.  Involvement of rat gonadotrope progesterone receptor in the ovary-mediated inhibitory action of FSH on LH synthesis.

Authors:  Ana Gordon; José Carlos Garrido-Gracia; José E Sánchez-Criado; Rafaela Aguilar
Journal:  J Physiol Biochem       Date:  2010-11-18       Impact factor: 4.158

4.  Effects of progesterone (P) and antiprogestin RU486 on LH and FSH release by incubated pituitaries from rats treated with the SERM LY11701 8-HCl and/or recombinant human FSH.

Authors:  C Bellido; R Aguilar; J C Garrido-Gracia; J E Sánchez-Criado
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

5.  Selection of gonadotrophin surge attenuating factor phage antibodies by bioassay.

Authors:  Tarja Sorsa-Leslie; Helen D Mason; William J Harris; Paul A Fowler
Journal:  Reprod Biol Endocrinol       Date:  2005-09-26       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.